Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

8 treatments under study, led by Parental Questionnaire

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (2)

Trial Status

Completed2

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 2 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT03928457Not ApplicableCompleted

Impact of Chronic Exposure to Radiofrequency Electromagnetic Fields on Neurophysiological Development in the Preterm Neonate

NCT06450613Not ApplicableCompleted

Cost-effectiveness of RFA vs. PEI for Early-stage HCC

Showing all 2 trials

Research Network

Common Treatments

  • Parental Questionnaire1
  • Daily Continuous Recording Of Radiofrequency Exposure Levels1
  • Radiofrequency Ablation1
  • Followup Of Daily Infants Environmental And Clinical Parameters1
  • Percutaneous Ethanol Injection1

Active Sponsors

  • Hospital Israelita Albert Einstein1
  • Centre Hospitalier Universitaire, Amiens1

Top Investigators

Related Conditions

  • Preterm Infant1
  • Cost Effectiveness1

Activity Timeline